Metraipolis › archive › dc_aa5cbb44d3e7

Utilization and Dose Optimization of Angiotensin-Converting Enzyme Inhibitors in Heart Failure Patients With Reduced Ejection Fraction: A Cross Sectional… — Europe PMC PMID:41211520

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41211520
DOI
10.1002/hsr2.71451
License (as archived)
solo-consultazione
Archived
2026-11-08T18:35:46.729Z
SHA-256 of the archived text
339cde1eb989059e7b87ccb1efba6c546062502a603551f5bffd8c4d642ec8eb
Stable URL of this page
https://metraipolis.com/documento/dc_aa5cbb44d3e7

How to cite

Utilization and Dose Optimization of Angiotensin-Converting Enzyme Inhibitors in Heart Failure Patients With Reduced Ejection Fraction: A Cross Sectional… — Europe PMC PMID:41211520 — Europe PMC (en), https://europepmc.org/article/MED/41211520 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aa5cbb44d3e7 (Metraipolis archive dc_aa5cbb44d3e7, sha256 339cde1eb989059e7b87ccb1efba6c546062502a603551f5bffd8c4d642ec8eb)
BibTeX
@misc{dcaa5cbb44d3e7,
  title = {Utilization and Dose Optimization of Angiotensin-Converting Enzyme Inhibitors in Heart Failure Patients With Reduced Ejection Fraction: A Cross Sectional… — Europe PMC PMID:41211520},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41211520},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aa5cbb44d3e7; sha256 339cde1eb989059e7b87ccb1efba6c546062502a603551f5bffd8c4d642ec8eb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41211520. Agents can read the archived copy with the MCP tool read_document.